NCT05842135

Brief Summary

AIM OF THE STUDY The aim of the study is to develop a Resectability Laparoscopic Score as a helpful instrument during intraoperative decision-making in the setting of emergency laparoscopic surgery for small bowel obstruction (SBO) by analyzing a multicenter data registry. DESIGN OF THE STUDY This is a multicenter study composed of a first phase of prospective data collection from patients that undergo laparoscopic surgery with a diagnosis of SBO and undergo Indocyanine green (ICG) fluorescence angiography (FA) for doubts about bowel viability after the resolution of the obstructive mechanism; the second phase of retrospective analysis to develop the Resectability Score. METHODS The FA should be performed in all patients undergoing laparoscopic surgery for SBO that presents concerns bowel viability after the resolution of the occlusive mechanism, with consequent intraoperative enrolment in the study Registry. The investigators adopted the modified Bulkley classification of the fluorescent patterns to identify which patients need more FA to assess bowel vitality. It is expected that most patients for whom the FA will be performed are those with patterns 2 or 3, representing the study's primary object. All participant centers must adopt the same technique to perform FA with the attempt to homogenize the procedure. Twenty-five milligrams of ICG powder is suspended in 10 ml of sterile water and administered intravenously through a peripheral vein and in small repeatable boluses of 2 ml in order to evaluate the intestinal microcirculation extemporaneously. The presence and pattern of arterial supply is tested and compared with that of healthy bowel. Proper clearance of the dye was also appraised to verify adequate venous drainage. Following the reversal of the underlying cause of the ischaemic injury, and after generous irrigation with warm saline, the involved bowel segment was further evaluated with FA after 10 min, regardless of the return of visible peristalsis. Routine postoperative clinical judgment will be considered sufficient to check bowel vitality. The need for a second-look surgery and delayed resections will be recorded. All centers could participate with a maximum of 3-4 members (co-authorship) Data will be recorded by a simple and brief online Case Report Form (CRF) on which upload also a photo/brief video of the FA, will be filled out by every participating center for each patient. A link to a Google Form and the necessary documents will be sent to every center after they have accepted to participate in the study.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
171

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Dec 2022

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

December 15, 2022

Completed
4 months until next milestone

First Submitted

Initial submission to the registry

April 11, 2023

Completed
22 days until next milestone

First Posted

Study publicly available on registry

May 3, 2023

Completed
8 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2023

Completed
6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

June 30, 2024

Completed
Last Updated

February 10, 2025

Status Verified

April 1, 2024

Enrollment Period

1 year

First QC Date

April 11, 2023

Last Update Submit

February 7, 2025

Conditions

Keywords

indocyanine green fluorescencesmall bowel obstructionfluorescent angiographyresectability scorelaparoscopic emergency surgery

Outcome Measures

Primary Outcomes (1)

  • Development of a resectability laparoscopic score based on data of a multicentric data registry

    Based on these items a resectability laparoscopic score is developed: * Length of compromised bowel expressed in centimeters * Quality of peritoneal fluid * Time to presence of peristalsis after resolution of the obstruction expressed in minutes * Time of return to healty bowel coloration after resolution of the obstruction expressed in minutes * ICG-fluorescence angiographic patterns * Bowel resection rate expressed as event/non event * Reintervention rate expressed as event/non event * Date of reintervention expressed in days * Delayed bowel resection rate expressed as event/non event

    Event occurred at the time of surgery or after the first surgical interventional without bowel resection

Secondary Outcomes (1)

  • Development of a multicentric data registry of patients underwent laparoscopic approach to small bowel obstruction and ICG fluorescent angiography

    12 months eventually extended by further 6 months

Interventions

Bowel viability assessment by indocyanine green fluorescent angiography during laparoscopic approach to small bowel obstruction

Also known as: indocyanine green fluorescent angiograhy

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

All patients more undergoing emergency laparoscopic surgery for SBO with intraoperative doubts about bowel viability after the resolution of the occlusive mechanism

You may qualify if:

  • All centers that routinely perform emergency laparoscopic surgery for SBO and have imaging systems with technology for the detection of near-infrared/indocyanine green fluorescence
  • All patients more than 18 years old undergoing emergency laparoscopic surgery for SBO with intraoperative doubts about bowel viability after the resolution of the occlusive mechanism

You may not qualify if:

  • Open surgical procedure for SBO

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Department of General Surgery, San Salvatore Hospital , AST Pesaro-Urbino

Pesaro, Pesaro-Urbino, 61121, Italy

Location

Study Officials

  • DIEGO COLETTA, MD

    San Salvatore Hospital, AST Pesaro-Urbino

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
CASE CROSSOVER
Time Perspective
OTHER
Target Duration
1 Week
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

April 11, 2023

First Posted

May 3, 2023

Study Start

December 15, 2022

Primary Completion

December 31, 2023

Study Completion

June 30, 2024

Last Updated

February 10, 2025

Record last verified: 2024-04

Data Sharing

IPD Sharing
Will not share

Locations